Integrating molecular and clinical variables to predict myocardial recovery
Visker, J. R.; Brintz, B. J.; Kyriakopoulos, C. P.; Hillas, Y.; Taleb, I.; Badolia, R.; Shankar, T. S.; Amrute, J. M.; Ling, J.; Hamouche, R.; Tseliou, E.; Navankasattusas, S.; Wever-Pinzon, O.; Ducker, G. S.; Holland, W. L.; Summers, S. A.; Koenig, S. C.; Hanff, T. C.; Lavine, K. J.; Murali, S.; Bailey, S.; Alharethi, R.; Selzman, C. H.; Shah, P.; Slaughter, M. S.; Kanwar, M. K.; Drakos, S. G.
Show abstract
Mechanical unloading and circulatory support with left ventricular assist devices (LVADs) mediate significant myocardial improvement in a subset of advanced heart failure (HF) patients. The clinical and biological phenomena associated with cardiac recovery are under intensive investigation. Left ventricular (LV) apical tissue, alongside clinical data, were collected from HF patients at the time of LVAD implantation (n=208). RNA was isolated and mRNA transcripts were identified through RNA sequencing and confirmed with RT-qPCR. To our knowledge this is the first study to combine transcriptomic and clinical data to derive predictors of myocardial recovery. We used a bioinformatic approach to integrate 59 clinical variables and 22,373 mRNA transcripts at the time of LVAD implantation for the prediction of post-LVAD myocardial recovery defined as LV ejection fraction (LVEF) [≥]40% and LV end-diastolic diameter (LVEDD) [≤]5.9cm, as well as functional and structural LV improvement independently by using LVEF and LVEDD as continuous variables, respectively. To substantiate the predicted variables, we used a multi-model approach with logistic and linear regressions. Combining RNA and clinical data resulted in a gradient boosted model with 80 features achieving an AUC of 0.731{+/-}0.15 for predicting myocardial recovery. Variables associated with myocardial recovery from a clinical standpoint included HF duration, pre-LVAD LVEF, LVEDD, and HF pharmacologic therapy, and LRRN4CL (ligand binding and programmed cell death) from a biological standpoint. Our findings could have diagnostic, prognostic, and therapeutic implications for advanced HF patients, and inform the care of the broader HF population. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=170 HEIGHT=200 SRC="FIGDIR/small/589326v1_ufig1.gif" ALT="Figure 1"> View larger version (46K): org.highwire.dtl.DTLVardef@17f0503org.highwire.dtl.DTLVardef@2231c1org.highwire.dtl.DTLVardef@f0ac56org.highwire.dtl.DTLVardef@c278f3_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Fragmented QRS is independently predictive of long-term adverse clinical outcomes in Asian patients hospitalized for heart failure: a retrospective cohort study 94%
- Simultaneous assessment of mechanical and electrical function in Langendorff-perfused ex-vivo mouse heart 94%
- Autologous cardiac micrografts as support therapy to coronary artery bypass surgery 94%
Similar papers in this journal
- Development and validation of imaging-free myocardial fibrosis prediction models, association with outcomes, and sample size estimation for phase 3 trials 96%
- Heart failure, female sex and atrial fibrillation are the main drivers of human atrial cardiomyopathy: results from the CATCH ME consortium 95%
- Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post-Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic Arrest 94%
Similar papers in this journal
- Ryanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function and prevents sudden arrhythmic death in failing hearts 95%
- Human induced pluripotent stem cell-derived cardiomyocytes to study inflammation-induced diastolic dysfunction 94%
- SIRT2 inhibition protects against cardiac hypertrophy and heart failure 94%
Similar papers in this journal
- Translation of Immunomodulatory Therapy to Treat Chronic Heart Failure: Preclinical Studies to First in Human 94%
- External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure 93%
- Genetic ablation of serotonin receptor 2B improves aortic valve hemodynamics in a high-cholesterol diet mouse model 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.